Advertisement
Logos iRiS
Logos iRiS

The Scientist

» FDA and culture

Most Recent

image: Drug Produced in GM Chicken Approved

Drug Produced in GM Chicken Approved

By | December 10, 2015

The US Food and Drug Administration greenlights a rare-disease drug that is produced in the eggs of genetically modified chickens.

1 Comment

image: Capsule Reviews

Capsule Reviews

By | December 1, 2015

Welcome to the Microbiome, The Paradox of Evolution, Newton's Apple, and Dawn of the Neuron.

0 Comments

image: Self Correction

Self Correction

By | December 1, 2015

What to do when you realize your publication is fatally flawed

0 Comments

image: Fatal-Disease Drug in Limbo

Fatal-Disease Drug in Limbo

By | November 25, 2015

A panel of experts advised the US Food and Drug Administration that BioMarin Pharmaceutical has not demonstrated efficacy of its new drug for Duchenne muscular dystrophy.

0 Comments

image: Agar Shortage Limits Lab Supplies

Agar Shortage Limits Lab Supplies

By | November 24, 2015

One large provider says the shortfall should clear up by early 2016.

1 Comment

image: FDA OKs GM Salmon

FDA OKs GM Salmon

By | November 19, 2015

AquaBounty Technologies’s fast-growing fish is the first genetically modified animal approved by the US Food and Drug Administration.

0 Comments

image: FDA: Lab Tests Can Cause Harm

FDA: Lab Tests Can Cause Harm

By | November 17, 2015

The US Food and Drug Administration cites cases in which laboratory-developed tests “may have caused or have caused actual harm to patients.”

1 Comment

image: Clinical Trial Data Underreported: Study

Clinical Trial Data Underreported: Study

By | November 16, 2015

One-third of the human experiments for approved drugs failed transparency requirements.

0 Comments

image: Following the Funding

Following the Funding

By | November 4, 2015

Researchers use network theory to estimate the importance of relationships among researchers and institutions in attracting grant money.

0 Comments

image: Battling the Bulge

Battling the Bulge

By | November 1, 2015

Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

0 Comments

Popular Now

  1. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  2. First Data from Anti-Aging Gene Therapy
  3. Locating Language within the Brain
  4. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

Advertisement
Gilson
Gilson
Advertisement
RayBioTech